10:41 PM EST, 01/06/2022 (MT Newswires) -- Sinco Pharmaceuticals Holdings (HKG:6833) said the management committee of Chengdu Tianfu International Biological City will back the company's smart medical aesthetic industrial park project in Chengdu City, China.
In a letter, the committee said it will offer government services and resources for the pharma marketing service provider's project, as well as for its research and development and industrialization plans for medical aesthetic products, according to a late Thursday filing.
Sinco Pharma said it will collaborate with the committee and relevant government authorities to negotiate the support scheme.
Shares jumped over 2% recently.
Price (HKD): $1.94, Change: $+0.04, Percent Change: +2.11%